Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes

Virology

Volumn 353, Issue 1, 2006, Pages 200-209

  Karstensen, Bernd ^a   Poppelreuther, Sven ^a   Bonin, Michael ^a   Walter, Michael ^a   Iftner, Thomas ^a   Stubenrauch, Frank ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

E1; E2F; Gene expression profiling; HPV18; Integration; Interferon

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; OLIGONUCLEOTIDE; PROTEIN E6; PROTEIN E7; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL LINE; CONTROLLED STUDY; EPISOME; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS GENOME; WILD TYPE;

CELL LINE; COCULTURE TECHNIQUES; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 18; HUMANS; INTERFERONS; KERATINOCYTES; MALE; PLASMIDS; UP-REGULATION; VIRUS INTEGRATION;

PAPILLOMAVIRIDAE;

EID: 33748159277     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.030     Document Type: Article

References (62)

1. Alazawi W., Pett M., Arch B., Scott L., Freeman T., Stanley M.A., and Coleman N. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res. 62 23 (2002) 6959-6965
2. Banno T., Gazel A., and Blumenberg M. Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes. J. Biol. Chem. 280 19 (2005) 18973-18980
3. Barnard P., and McMillan N.A. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259 2 (1999) 305-313
4. Blachon S., and Demeret C. The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic. Biochimie 85 8 (2003) 813-819
5. Bouvard V., Storey A., Pim D., and Banks L. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J. 13 22 (1994) 5451-5459
6. Cam H., Balciunaite E., Blais A., Spektor A., Scarpulla R.C., Young R., Kluger Y., and Dynlacht B.D. A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell 16 3 (2004) 399-411
7. Chang Y.E., and Laimins L.A. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74 9 (2000) 4174-4182
8. Chin K.C., and Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 98 26 (2001) 15125-15130
9. Chung C.H., Bernard P.S., and Perou C.M. Molecular portraits and the family tree of cancer. Nat. Genet. 32 (2002) 533-540
10. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., and El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 6 4 (2005) 204
11. Corden S.A., Sant-Cassia L.J., Easton A.J., and Morris A.G. The integration of HPV-18 DNA in cervical carcinoma. Mol. Pathol. 52 5 (1999) 275-282
12. Cullen A.P., Reid R., Campion M., and Lorincz A.T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65 2 (1991) 606-612
13. Davy C.E., Jackson D.J., Wang Q., Raj K., Masterson P.J., Fenner N.F., Southern S., Cuthill S., Millar J.B., and Doorbar J. Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J. Virol. 76 19 (2002) 9806-9818
14. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95 26 (1998) 15623-15628
15. Durst M., Kleinheinz A., Hotz M., and Gissman L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J. Gen. Virol. 66 Pt. 7 (1985) 1515-1522
16. Frattini M.G., Lim H.B., and Laimins L.A. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl. Acad. Sci. U.S.A. 93 7 (1996) 3062-3067
17. Frattini M.G., Lim H.B., Doorbar J., and Laimins L.A. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol. 71 9 (1997) 7068-7072
18. Fu B., Quintero J., and Baker C.C. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes. Cancer Res. 63 22 (2003) 7815-7824
19. Fuchs P.G., Girardi F., and Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?. Int. J. Cancer 43 1 (1989) 41-44
20. Garner-Hamrick P.A., Fostel J.M., Chien W.M., Banerjee N.S., Chow L.T., Broker T.R., and Fisher C. Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J. Virol. 78 17 (2004) 9041-9050
21. Havard L., Delvenne P., Frare P., Boniver J., and Giannini S.L. Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes. Virology 298 2 (2002) 271-285
22. Heinz S., Haehnel V., Karaghiosoff M., Schwarzfischer L., Muller M., Krause S.W., and Rehli M. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J. Biol. Chem. 278 24 (2003) 21502-21509
23. Hinata K., Gervin A.M., Jennifer Zhang Y., and Khavari P.A. Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. Oncogene 22 13 (2003) 1955-1964
24. Huang S.M., and McCance D.J. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J. Virol. 76 17 (2002) 8710-8721
25. Hudelist G., Manavi M., Pischinger K.I., Watkins-Riedel T., Singer C.F., Kubista E., and Czerwenka K.F. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 92 3 (2004) 873-880
26. Ishida S., Huang E., Zuzan H., Spang R., Leone G., West M., and Nevins J.R. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21 14 (2001) 4684-4699
27. Jeon S., Allen-Hoffmann B.L., and Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69 5 (1995) 2989-2997
28. Kelley M.L., Keiger K.E., Lee C.J., and Huibregtse J.M. The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J. Virol. 79 6 (2005) 3737-3747
29. Kho P.S., Wang Z., Zhuang L., Li Y., Chew J.L., Ng H.H., Liu E.T., and Yu Q. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J. Biol. Chem. 279 20 (2004) 21183-21192
30. Klaes R., Friedrich T., Spitkovsky D., Ridder R., Rudy W., Petry U., Dallenbach-Hellweg G., Schmidt D., and von Knebel Doeberitz M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92 2 (2001) 276-284
31. Klingelhutz A.J., Foster S.A., and McDougall J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380 6569 (1996) 79-82
32. Leaman D.W., Chawla-Sarkar M., Vyas K., Reheman M., Tamai K., Toji S., and Borden E.C. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. J. Biol. Chem. 277 32 (2002) 28504-28511
33. Li S., Labrecque S., Gauzzi M.C., Cuddihy A.R., Wong A.H., Pellegrini S., Matlashewski G.J., and Koromilas A.E. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18 42 (1999) 5727-5737
34. Markey M.P., Angus S.P., Strobeck M.W., Williams S.L., Gunawardena R.W., Aronow B.J., and Knudsen E.S. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res. 62 22 (2002) 6587-6597
35. Meyers C., Mayer T.J., and Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71 10 (1997) 7381-7386
36. Muller H., Bracken A.P., Vernell R., Moroni M.C., Christians F., Grassilli E., Prosperini E., Vigo E., Oliner J.D., and Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15 3 (2001) 267-285
37. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., and Zacny V.L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20 54 (2001) 7888-7898
38. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 6 (2003) 518-527
39. Nakahara T., Nishimura A., Tanaka M., Ueno T., Ishimoto A., and Sakai H. Modulation of the cell division cycle by human papillomavirus type 18 E4. J. Virol. 76 21 (2002) 10914-10920
40. Nees M., Geoghegan J.M., Hyman T., Frank S., Miller L., and Woodworth C.D. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J. Virol. 75 9 (2001) 4283-4296
41. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 49 (1999) 6853-6866
42. Patel D., Huang S.M., Baglia L.A., and McCance D.J. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18 18 (1999) 5061-5072
43. Pater M.M., and Pater A. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145 2 (1985) 313-318
44. Perea S.E., Massimi P., and Banks L. Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int. J. Mol. Med. 5 6 (2000) 661-666
45. Pirami L., Giache V., and Becciolini A. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J. Clin. Pathol. 50 7 (1997) 600-604
46. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., and Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16 2 (2002) 245-256
47. Ronco L.V., Karpova A.Y., Vidal M., and Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12 13 (1998) 2061-2072
48. Ruutu M., Peitsaro P., Johansson B., and Syrjanen S. Transcriptional profiling of a human papillomavirus 33-positive squamous epithelial cell line which acquired a selective growth advantage after viral integration. Int. J. Cancer 100 3 (2002) 318-326
49. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 6 (1990) 1129-1136
50. Schneider-Gadicke A., and Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5 9 (1986) 2285-2292
51. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., and zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 6006 (1985) 111-114
52. Semizarov D., Kroeger P., and Fesik S. siRNA-mediated gene silencing: a global genome view. Nucleic Acids Res. 32 13 (2004) 3836-3845
53. Shirasawa H., Tomita Y., Fuse A., Yamamoto T., Tanzawa H., Sekiya S., Takamizawa H., and Simizu B. Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line. J. Gen. Virol. 70 Pt. 7 (1989) 1913-1919
54. Spitkovsky D., Hehner S.P., Hofmann T.G., Moller A., and Schmitz M.L. The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J. Biol. Chem. 277 28 (2002) 25576-25582
55. Sprague D.L., Phillips S.L., Mitchell C.J., Berger K.L., Lace M., Turek L.P., and Klingelhutz A.J. Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. Virology 301 2 (2002) 247-254
56. Stubenrauch F., Hummel M., Iftner T., and Laimins L.A. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J. Virol. 74 3 (2000) 1178-1186
57. Vernell R., Helin K., and Muller H. Identification of target genes of the p16INK4A-pRB-E2F pathway. J. Biol. Chem. 278 46 (2003) 46124-46137
58. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., Liu J., Zhao X.D., Chew J.L., Lee Y.L., Kuznetsov V.A., Sung W.K., Miller L.D., Lim B., Liu E.T., Yu Q., Ng H.H., and Ruan Y. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 1 (2006) 207-219
59. Wentzensen N., Vinokurova S., and von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 64 11 (2004) 3878-3884
60. Wilczynski S.P., Pearlman L., and Walker J. Identification of HPV 16 early genes retained in cervical carcinomas. Virology 166 2 (1988) 624-627
61. Wong Y.F., Cheung T.H., Tsao G.S., Lo K.W., Yim S.F., Wang V.W., Heung M.M., Chan S.C., Chan L.K., Ho T.W., Wong K.W., Li C., Guo Y., Chung T.K., and Smith D.I. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int. J. Cancer 118 10 (2006) 2461-2469
62. Zhang N., Ahsan M.H., Zhu L., Sambucetti L.C., Purchio A.F., and West D.B. NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation. J. Biol. Chem. 280 22 (2005) 21400-21408